The following information was taken from the 2004 financial statement of pharmecutical giant Merck and CO. All dollar amounts are in millions.
Retained earnings, January 1, 2004 34,142.0
Materials and production expense 4,959.8
Marketing and administrative expense 7,346.3
Dividends 3,329.1
Sales Revenue 22,938.6
Research and development expense 4,010.2
Tax Expense 2,161.1
Other revenue 1,352.2
Prepare income statement
